Bishop EJ, et al. - A scrutiny was carried out of the efficacy and adverse effects related to tigecycline combination therapy for severe and severe-complicated Clostridium difficile infection (CDI) in an Australian health-care setting. Researchers drew the conclusion that tigecycline was safe and effective as a combination therapy in severe CDI. Its use was recommended earlier and for shorter durations.